Example: Heart Attack

Clinical Trials Sponsored by Sidney Kimmel Comprehensive Cancer Center

Total 502 results

    • NCT01732640
      Terminated
      A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
      Conditions: Squamous Cell Carcinoma of the Head and Neck
    • NCT03035773
      Active, not recruiting
      Simplifying Survivorship Care Planning
      Conditions: Cancer
    • NCT04524195
      Not yet recruiting
      PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC)
      Conditions: Non-small Cell Lung Cancer (NSCLC)
    • NCT04499950
      Not yet recruiting
      Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
      Conditions: Breast Cancer; Overweight or Obesity
    • NCT04713046
      Not yet recruiting
      Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
      Conditions: HPV 16+ Recurrent or Metastatic Cancer
    • NCT04704505
      Not yet recruiting
      Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
      Conditions: Prostate Adenocarcinoma; Metastatic Prostate Adenocarcinoma; Castration-resistant
    • NCT04658147
      Not yet recruiting
      Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
      Conditions: Hepatocellular Carcinoma
    • NCT04652765
      Not yet recruiting
      Camostat With Bicalutamide for COVID-19
      Conditions: Covid19; SARS-CoV Infection; Coronavirus Infection
    • NCT04589247
      Recruiting
      Improving Cancer Symptom Management
      Conditions: Cancer; Thoracic Neoplasms; Gastrointestinal Cancer; Lung Cancer
    • NCT04534309
      Recruiting
      Behavioral Weight Loss Program for Cancer Survivors in Maryland
      Conditions: Breast Cancer; Prostate Cancer; Melanoma (Skin); Endometrial Cancer; Gallbladder Cancer; Rectal Cancer; Kidney Cancer; Bladder Cancer
    • NCT04530019
      Not yet recruiting
      Brachytherapy Innovations in Gynecologic Cancer
      Conditions: Gynecologic Cancer
    • NCT04528199
      Recruiting
      [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
      Conditions: Metastatic Prostate Cancer
    • NCT04517643
      Recruiting
      TheraSphere® For Treatment of Metastases in Liver
      Conditions: Colorectal Cancer Metastatic; Colorectal Cancer
    • NCT04266431
      Recruiting
      EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
      Conditions: Prostatic Neoplasm
    • NCT04248569
      Recruiting
      DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
      Conditions: Fibrolamellar Hepatocellular Carcinoma (FLC)
    • NCT04465643
      Not yet recruiting
      Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
      Conditions: Nerve Sheath Tumors
    • NCT04447651
      Recruiting
      Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
      Conditions: Metastatic Breast Cancer; SF3B1 Gene Mutation; Spliceosome Mutation
    • NCT04131413
      Recruiting
      HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
      Conditions: Human Papillomavirus Type 16; Cervical Intraepithelial Neoplasia Grade II; Cervical Intraepithelial Neoplasia, Grade III
    • NCT04177810
      Recruiting
      Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
      Conditions: Metastatic Pancreatic Cancer
    • NCT04386746
      Recruiting
      Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
      Conditions: Urothelial Carcinoma Bladder; Bladder Cancer
    • NCT04376229
      Recruiting
      Proton Radiation Therapy Registry
      Conditions: Cancer, Therapy-Related
    • NCT04374279
      Not yet recruiting
      Trial to Promote Recovery From COVID-19 With Endocrine Therapy
      Conditions: COVID-19; SARS-CoV 2
    • NCT04363164
      Active, not recruiting
      Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
      Conditions: Castration Resistant Metastatic Prostate Cancer
    • NCT04331717
      Recruiting
      Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer
      Conditions: Prostate Adenocarcinoma; Obesity, Morbid
    • NCT04301778
      Recruiting
      Durvalumab in Combination With a CSF-1R Inhibitor (SNDX-6532) Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
      Conditions: Unresectable Intrahepatic Cholangiocarcinoma
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations